Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Maxcyte, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 81 | 1 | 104 | +24 |
| Shares | 54.6M | 10.5K | 67.2M | +12.6M (+23.1%) |
| Value | $665.4M | $128.0K | $683.6M | +$18.4M (+2.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Maxcyte, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (11)
Institutions that held Maxcyte, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Driehaus Capital Management LLC | 805,823 | $9.84M |
| Millennium Management LLC | 422,442 | $5.16M |
| Atika Capital Management LLC | 140,000 | $1.71M |
| AREX Capital Management, LP | 126,968 | $1.55M |
| Alyeska Investment Group, L.P. | 125,000 | $1.53M |
| Jane Street Group, LLC | 87,076 | $1.06M |
| Cubist Systematic Strategies, LLC | 31,600 | $386.0K |
| Tudor Investment Corp Et Al | 25,512 | $312.0K |
| Caas Capital Management LP | 10,000 | $122.0K |
| Point72 Hong Kong Ltd | 9,904 | $121.0K |
| Captrust Financial Advisors | 171 | $2.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 10,511 | $128.0K |